Evidence map›Paper›PMID 30637054›Full record

ArticleThe Pan African medical journal2018

[Intracranial tuberculomas in Nouakchott, Mauritania].

Sidi Salem-Memou, Samy Dadah, Ahmedou Moctar, Sidelhadj Dah, Ahmed Jeddou, Ahmedsalem Kleib, Sidimohamed Salihy, Outouma Soumare, Mouhamadou Diagana, Najat Boukhrissi

Abstract readMulticenter Study
In one paragraph

Article in The Pan African medical journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sidi Salem-MemouService de Neurochirurgie, Centre Hospitalier National de Nouakchott, Mauritanie.
Samy DadahService de Neurochirurgie, Centre Hospitalier National de Nouakchott, Mauritanie.
Ahmedou MoctarService de Neurochirurgie, Centre Hospitalier National de Nouakchott, Mauritanie.
Sidelhadj DahService de Neurochirurgie, Centre Hospitalier National de Nouakchott, Mauritanie.
Ahmed JeddouService de Neurochirurgie, Centre Hospitalier National de Nouakchott, Mauritanie.
Ahmedsalem KleibService de Neurochirurgie, Centre Hospitalier National de Nouakchott, Mauritanie.
Sidimohamed SalihyService de Neurochirurgie, Centre Hospitalier National de Nouakchott, Mauritanie.
Outouma SoumareService de Neurochirurgie, Centre Hospitalier National de Nouakchott, Mauritanie.
Mouhamadou DiaganaService de Neurochirurgie, Centre Hospitalier National de Nouakchott, Mauritanie.
Najat BoukhrissiService de Neurochirurgie, Centre Hospitalier National de Nouakchott, Mauritanie.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis is a major public health problem in developing countries. Cerebral tuberculomas is a tuberculous granulation tissue mass restrained and limited by immune defenses of the host. This study aims to describe the characteristics and the evolutionary profile of intracranial tuberculomas in Mauritania. Data of 34 patients with intracranial tuberculoma were collected retrospectively in several hospitals in the city of Nouakchott between January 2005 and June 2017. Evolutionary features of patients under treatment were analyzed. Our retrospective study involved 20 men and 14 women (sex ratio 1.4). The average age of our patients was 28.7 years. Twelve patients were less than or equal to 16 years. Symptomatology was dominated by increased intracranial pressure and seizures in 27 cases (79.41%) and 20 cases (58.82%) respectively. Intradermo tuberculin reaction was positive in 14 (41.17%) cases. Supratentorial lesion was found in 24 patients (70.58%). In all patients, therapeutic approach was based on multidrug chemotherapy for a period greater than or equal to 12 months. Surgical procedure was performed in 12 patients (35.29%). Outcome was favorable with complete healing without sequelae in 23 cases, reflecting a rate of 67.64%. Given the non-specific role of imaging exams in the diagnosis of intracranial tuberculoma and the lack of the stereotactic biopsy in our Country where the disease is endemic, we recommend to perform a two-month therapeutic test in patients with suspicious lesions.

Indexed as

AdolescentAdultAntitubercular AgentsChildFemaleHumansIntracranial HypertensionMaleMauritaniaMiddle AgedRetrospective StudiesSeizuresTreatment OutcomeTuberculin TestTuberculoma, IntracranialYoung AdultAntitubercular AgentsCerebral tuberculomaMauritaniatuberculosis

Identifiers

PMID30637054
PMCPMC6317400

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.